Upper Limb Intensive Therapies in Babies With Unilateral Cerebral Palsy.

Sponsor
CEU San Pablo University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04642872
Collaborator
(none)
40
1
4
19.7
2

Study Details

Study Description

Brief Summary

mCIMT and BIT are therapies applied in children with hemiplegia which have a great evidence, but not in a early age. This research has the objective to know the effects of this therapies in infants diagnosed of infantile hemiplegia from 9 to 18 months applying 50 hours of dose for both interventions during 10 weeks, executing them at home by familes.

Condition or Disease Intervention/Treatment Phase
  • Other: Infant BIT
  • Other: Infant CIMT/BIT
  • Other: Conventional therapy
  • Other: infant cimt
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effects of Infant Constraint Induced Movement Therapy and Infant Bimanual Intensive Therapy in Unilateral Cerebral Palsy. A Randomized Controlled Trial.
Actual Study Start Date :
Jul 28, 2019
Anticipated Primary Completion Date :
Jan 18, 2021
Anticipated Study Completion Date :
Mar 20, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: infant cimt

Other: Infant BIT
Not use of unaffected hand containment. Both hand are use to improve the bimanual coordination

Other: Infant CIMT/BIT
Use unaffected hand containment in part of the intervention and then, both hands in bimanual activities without containment.

Other: Conventional therapy
Following the usual therapy in the baby.

Active Comparator: Infant BIT

Other: Infant CIMT/BIT
Use unaffected hand containment in part of the intervention and then, both hands in bimanual activities without containment.

Other: Conventional therapy
Following the usual therapy in the baby.

Other: infant cimt
use of unaffected hand containment to improve the use of affected hand with unimanual activities

Active Comparator: Infant CIMT/BIT

Other: Infant BIT
Not use of unaffected hand containment. Both hand are use to improve the bimanual coordination

Other: Conventional therapy
Following the usual therapy in the baby.

Other: infant cimt
use of unaffected hand containment to improve the use of affected hand with unimanual activities

Active Comparator: Conventional Therapy

Other: Infant BIT
Not use of unaffected hand containment. Both hand are use to improve the bimanual coordination

Other: Infant CIMT/BIT
Use unaffected hand containment in part of the intervention and then, both hands in bimanual activities without containment.

Other: infant cimt
use of unaffected hand containment to improve the use of affected hand with unimanual activities

Outcome Measures

Primary Outcome Measures

  1. mini Assisting Hand Assesment [10 weeks]

    Bimanual functional performance Assessment in children with hemiplegia from 8 to 18 months.

Secondary Outcome Measures

  1. Satisfaction questionnaire for familes [10 weeks]

    Descriptive questionnaire to obtain the adherence and satisfaction from families in this therapies.

Eligibility Criteria

Criteria

Ages Eligible for Study:
9 Months to 18 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Infantile hemiplegia

  • Age from 9 months to 18 months.

  • No use of the affected upper limb

Exclusion Criteria:
  • Associated pathologies

  • Epilepsy no controlled with medicins

  • No collaborated families

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hemiweb Barcelona Spain

Sponsors and Collaborators

  • CEU San Pablo University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rocio Palomo CarriĆ³n, Director, CEU San Pablo University
ClinicalTrials.gov Identifier:
NCT04642872
Other Study ID Numbers:
  • infant CIMT/BIT
First Posted:
Nov 24, 2020
Last Update Posted:
Nov 24, 2020
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 24, 2020